CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Barcelona, Spain; Diabetes and Metabolism Research Unit, Vall Hebron Institut de Recerca, Barcelona, Spain.
Diabetes Metab Res Rev. 2013 Sep;29(6):499-506. doi: 10.1002/dmrr.2419.
Diabetic macular edema is the main cause of visual impairment in diabetic patients. The aim of the present study was to explore the differential proteomic pattern of the vitreous fluid from diabetic macular edema patients by means of fluorescence-based difference gel electrophoresis (DIGE).
Samples of vitreous from eight type 2 diabetic patients [four with diabetic macular edema without proliferative diabetic retinopathy and four with proliferative diabetic retinopathy without diabetic macular edema), and eight from non-diabetic subjects with idiopathic macular hole (control group) were selected from our vitreous bank for proteomic analysis. To further confirm the potential candidates identified by DIGE, 18 additional samples (six proliferative diabetic retinopathy, six diabetic macular edema and six macular hole, matched by age) were analysed by enzyme-linked immuno sorbent assay (ELISA).
Selecting an abundance ratio of 1.5-fold, p < 0.05, as the threshold for the study, four proteins were specifically associated with diabetic macular edema. Hemopexin was significantly higher in the vitreous fluid of patients with diabetic macular edema in comparison with both control subjects and proliferative diabetic retinopathy patients. By contrast, clusterin, transthyretin and crystallin S were significantly decreased in the vitreous of patients with diabetic macular edema. The differential production of hemopexin, clusterin and transthyretin was further confirmed by ELISA.
Proteomic analysis by DIGE was useful in identifying new potential candidates involved in the pathogenesis of diabetic macular edema. These results could open up new strategies in the treatment of diabetic macular edema.
糖尿病性黄斑水肿是糖尿病患者视力损害的主要原因。本研究旨在通过荧光差异凝胶电泳(DIGE)方法探索糖尿病性黄斑水肿患者的玻璃体液中差异表达蛋白质组学图谱。
从我们的玻璃体库中选择了 8 例 2 型糖尿病患者(4 例无增殖性糖尿病性视网膜病变的糖尿病性黄斑水肿和 4 例无糖尿病性黄斑水肿的增殖性糖尿病性视网膜病变)和 8 例非糖尿病性特发性黄斑裂孔患者(对照组)的玻璃体样本进行蛋白质组学分析。为了进一步证实 DIGE 鉴定出的潜在候选物,通过酶联免疫吸附试验(ELISA)分析了另外 18 个样本(6 个增殖性糖尿病性视网膜病变、6 个糖尿病性黄斑水肿和 6 个黄斑裂孔,年龄匹配)。
选择丰度比为 1.5 倍,p < 0.05 作为研究的阈值,发现有 4 种蛋白质与糖尿病性黄斑水肿特异性相关。与对照组和增殖性糖尿病性视网膜病变患者相比,在糖尿病性黄斑水肿患者的玻璃体液中,血红素结合蛋白显著升高。相反,在糖尿病性黄斑水肿患者的玻璃体中,簇蛋白、转甲状腺素蛋白和晶状体 S 显著降低。ELISA 进一步证实了血红素结合蛋白、簇蛋白和转甲状腺素蛋白的差异产生。
DIGE 的蛋白质组学分析有助于识别新的潜在候选物,参与糖尿病性黄斑水肿的发病机制。这些结果可能为糖尿病性黄斑水肿的治疗开辟新的策略。